Mantle cell lymphoma: established therapeutic options and future directions

ISSN： 0939-5555

Source： Annals of Hematology, Vol.83, Iss.2, 2004-02, pp. : 71-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment

By Zhang Liang Newberry Kate J Wang Michael

Expert Review of Clinical Immunology, Vol. 9, Iss. 6, 2013-06 ,pp. : 495-497

Informa Healthcare

Access to resources Recommend Favorite

Molecular characterization of composite mantle cell and follicular lymphoma

By Zamò Alberto Zanotti Roberta Lestani Maurizio Ott German Katzenberger Tiemo Scarpa Aldo Pizzolo Giovanni Menestrina Fabio Chilosi Marco

Virchows Archiv, Vol. 448, Iss. 5, 2006-05 ,pp. : 639-643

Springer Publishing Company

Access to resources Recommend Favorite

Primary mantle cell lymphoma of the conjunctiva: a case report

By Aspiotis Miltiadis Gorezis Spiridon Asproudis Ioannis Tsanou Elena Papadiotis Evangelos Kamina Sevasti Agnantis Niki Bai Maria

Virchows Archiv, Vol. 449, Iss. 4, 2006-10 ,pp. : 472-475

Springer Publishing Company

Access to resources Recommend Favorite

Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma

By Tempescul Adrian

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 921-922

Springer Publishing Company

Access to resources Recommend Favorite

Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation

By Hutter G.

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 821-828

Springer Publishing Company

Access to resources Recommend Favorite